NGS Banner
Contributors

James Reid, Venu Pullabhatla, Laura Parkes, John Shovelton, Ezam Uddin, Lyudmila Georgieva, Aysel Heckel, Jolyon Holdstock, Graham Speight

 

Introduction

Next-Generation Sequencing (NGS) has enabled large-scale identification of variants with increased reliability and accuracy. This is crucial for detecting low-frequency variants for cancer research.

At OGT, we have developed Interpret, as a partner software tool to our CytoSure® and SureSeq™ NGS panels, to facilitate data analysis in an easy, user-friendly way. Interpret has been benchmarked with known and validated variants from control reference standards achieving high concordance.

Register with us to read the full article

Once you have registered with us for free you will be able to read all our supportive literature, video tutorials and webinars.

  • Share
You might also be interested in

Improving experimental reproducibility through automated hybridisation-based NGS library preparation

  • Resource type: App note
  • Application: Haematology, Solid tumour, Cytogenetics & rare disease
Read

Selecting the best NGS enrichment assay for your needs

  • Resource type: App note
  • Application: Haematology, Solid tumour, Cytogenetics & rare disease
Read
CTA Icon

Stay up-to-date with the latest news from OGT, including new products, support resources, and our DNA Dispatch newsletter